On May 23, 2021, Oramed Pharmaceuticals Inc. appointed David Silberman, 37, to serve as Chief Financial Officer, Treasurer and Secretary, effective July 5, 2021. Prior to his appointment, from April 2018 until May 2021, Mr. Silberman served as a Corporate Financial Planning and Analysis associate director and director at Teva Pharmaceutical Industries Ltd. From 2014 to 2018, Mr. Silberman served as Global Internal Audit Senior Manager at Teva Pharmaceutical Industries Ltd.